None listed
Conditions
Interventions
Intervention1: BUPIVACAINE (HEAVY): INTRATHECAL DOSE- 0.5% HEAVY 3.5 ML
DRUG TO BE GIVEN INTRATHECALLY WITHOUT ADDITIVES
Control Intervention1: GABAPENTIN: ORAL DOSE- 300 MG AND 600 MG
DRUG TO BE GIVE
Sponsors
MGM MEDICAL COLLEGE
MGM MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: BOTH MALE AND FEMALE PATIENTS OF AGE GROUP 18-65 YRS RECEIVING SPINAL ANAESTHESIA FOR ELECTIVE LOWER LIMB SURGERIES UNDER ASA GRADE 1 AND 2
Exclusion criteria
Exclusion criteria: 1. PATIENTS WITH ALLERGY TO GABAPENTIN 2. PATIENTS SUFFERING FROM EPILEPSY, LIVER AND RENAL DISEASE, ANY CHRONIC PAIN SYNDROMES, PSYCHIATRIC ILLNESS 3. PATIENTS REQUIRING SURGICAL DURATION MORE THAN 3 HOURS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COMPARE TOTAL DURATION OF ANALGESIA AND TOTAL NUMBER OF ANALGESICS REQUIRED IN THE FIRST 24 HOURS AFTER SURGERYTimepoint: 24 HOURS | — |
Secondary
| Measure | Time frame |
|---|---|
| COMPARE SIDE EFFECTS OF THE TWO DOSES OF GABAPENTIN IF ANYTimepoint: 24 HOURS | — |
Countries
India
Contacts
Public ContactMITALEE H PAREEK
MGM MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed